Home » Topics » BioWorld Science

BioWorld Science
RSS

Beijing Yuezhikangtai Biomedicines discloses VEGFR inhibitors

April 8, 2020

Roche patents Toll-like receptor antagonists

April 8, 2020

Preclinical data support development of WZ-66 for NASH

April 8, 2020

IXT-v100 vaccine decreases meth-taking and -seeking behaviors in vivo

April 8, 2020

Researchers in Montreal and NYU partner on new COVID-19 clinical study

April 8, 2020

Catalyst announces pivotal phase III design for MarzAA

April 8, 2020

CellCentric enters agreement with PCCTC for phase II dose-expansion study of CCS-1477

April 8, 2020

FDA approves the initiation of stem cell study for protection against COVID-19

April 8, 2020

Phase IIa study of golexanolone shows no clinical benefit

April 8, 2020

Stopping tau in its tracks

April 8, 2020

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...